• Targeted Peptide Nanocarriers Enhance Breast Cancer Therapy

  2026-09-16

  The reference study developed an acid-responsive, breast cancer-targeted peptide nanocarrier that co-delivers doxorubicin and triptolide. By combining tumor targeting, pH-triggered shape transformation, deeper tissue penetration, and immune modulation, the system improved antitumor activity in cellular and 4T1 tumor models.

• Tetrazolium Red: From Redox Signal to Translation

  2026-09-16

  Tetrazolium (chloride) converts dehydrogenase activity into a spatially resolved red formazan signal, helping translational researchers connect mitochondrial redox biology with cellular and tissue-level outcomes. This article examines how Tetrazolium Red can strengthen ischemic injury workflows, clarify study limitations, and improve the interpretation of neuroprotective evidence.

• Mc-Val-Cit-PABC-PNP ADC Linker Workflow

  2026-09-15

  Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable ADC peptide linker for research workflows that require protease-responsive payload release after antibody-drug conjugate internalization. It is suited to DMSO-based preparation and should not be used as a water- or ethanol-based reagent, or for diagnostic, clinical, or therapeutic applications.

• TBST Workflows for Clearer Immunoassay Signals

  2026-09-15

  TBST combines buffered saline with Tween 20 to support lower-background blocking and washing in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This practical guide connects detergent-aware assay handling with a conformationally informed cancer-biology study, showing where TBST can improve reproducibility and where it should be validated cautiously.

• Erastin: Ferroptosis Inducer Mechanism & Workflow

  2026-09-14

  Erastin is a small-molecule ferroptosis inducer that disrupts cystine-dependent antioxidant defense and promotes oxidative cell death. This guide connects its RAS/BRAF-associated experimental use with practical cancer biology research, assay controls, formulation limits, and evidence from a peer-reviewed developmental study.

• Catalpol Workflows for Neuroinflammation Research

  2026-09-14

  Build a reproducible Catalpol workflow around oxidative stress, NLRP3 inflammasome signaling, microglial activation, and behavior-linked tissue assays. This guide connects CUMS depression studies with practical dose selection, sample handling, pathway validation, and carefully bounded extensions into stroke, osteoporosis, and liver fibrosis research.

• Letrozole Workflows for Breast Cancer Research

  2026-09-13

  Use Letrozole to connect aromatase inhibition with estrogen depletion, estrogen receptor alpha downregulation, and endocrine feedback assays. This practical guide covers model selection, DMSO handling, concentration-response design, comparative endocrine experiments, and troubleshooting for reproducible breast cancer research.

• L-NMMA acetate for NOS Pathway Studies

  2026-09-12

  L-NMMA acetate enables controlled nitric oxide pathway modulation in cell-based mechanistic studies, including osteogenic differentiation assays. This practical guide shows how to pair pan-NOS inhibition with NO, cGMP, viability, and lineage-specific readouts while avoiding common interpretation and handling errors.

• Ivermectin: Broad-Spectrum Anti-Parasitic Research

  2026-09-11

  Ivermectin is a broad-spectrum anti-parasitic used in approved treatments for selected nematode and ectoparasite infections. Its validated chloride-channel pharmacology supports parasitology research, while current Gasdermin C cancer findings do not establish ivermectin as a pancreatic cancer therapy.

• HyperTrap Heparin HP Column: Workflow Guide

  2026-09-11

  Build reproducible heparin-affinity workflows for growth factors, coagulation proteins, and nucleic acid enzymes with a ready-to-use, high-resolution format. This guide connects column selection and troubleshooting to practical assay design inspired by CCR7–Notch1 stemness research.

• Dacomitinib (PF-00299804): Mechanism & Research Use

  2026-09-10

  Dacomitinib, also known as PF-00299804, is an irreversible pan-HER kinase inhibitor with reported activity against EGFR, HER2, and HER4. Its strongest research applications involve EGFR-driven non-small-cell lung carcinoma models and HER2-amplified breast cancer research, while ferroptosis findings from colorectal cancer remain mechanistic context rather than direct evidence for dacomitinib.

• Light, Brassinosteroids, and Arabidopsis Root Growth

  2026-09-10

  Peng and Zhai show that light and brassinosteroids regulate Arabidopsis seedling primary-root elongation through largely separable effects. Their genotype-by-environment and pharmacological design also indicates that brassinazole responses are context dependent, with toxicity complicating interpretation of brassinosteroid-deficiency experiments.

• 3X FLAG Peptide Workflow for Viral RNA Studies

  2026-09-09

  Use the 3X FLAG peptide to combine gentle affinity capture, sensitive fusion-protein detection, and interaction mapping in recombinant and virology workflows. Its triple epitope design is especially useful when preserving protein complexes or preparing tagged material for structural studies.

• Biotin-HPDP for Mapping Neuronal Thiol Dynamics

  2026-09-09

  Biotin-HPDP offers translational researchers a reversible way to convert dynamic cysteine chemistry into an affinity handle. This article connects its thiol-reactive mechanism with new evidence that PPT1–GAP43 depalmitoylation regulates neuronal excitability, while defining the controls needed to distinguish biochemical association from causal biology.

• Nav1.5 Ser571 Phosphorylation in Cardiac Aging

  2026-09-08

  The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic function during cardiac aging. By combining age comparisons with phosphomimetic and phosphoablated mouse models, the study moves beyond correlation and provides a framework for testing late sodium current as a modifiable component of the aging myopathy.

8132 records 1/543 page Next 12345 下5页 Last page